Crescent Discovery Series

A reading room for breakthroughs and the curious mind

AI could cut second-line UTI antibiotics by two-thirds

Doctors treating a urinary tract infection often have to guess which antibiotic will work before resistance results come back days later.

Crescent Bioresearch11 July, 4:34 PMKanjilal et al., Science Translational Medicine, 2020 · MIT and Harvard Medical School2 min read

Researchers at MIT and Harvard, using records from two Boston hospitals, built a machine learning model trained on patient history, prior antibiotic exposure and local resistance patterns to recommend the narrowest antibiotic likely to work for a given patient.

Tested retrospectively on 3,629 patients with urinary infections, the model's recommendations would have reduced use of broad-spectrum antibiotics while cutting prescriptions of second-line drugs by about 67 percent compared with what clinicians actually prescribed, while lowering the rate of ineffective treatment by 18 percent.

The analysis compared the algorithm's hypothetical choices against doctors' real decisions after the fact, rather than testing it prospectively on real patients in real time, so a live clinical trial is the next step. Overprescribing broad-spectrum antibiotics is a major driver of resistance, which is why even a retrospective signal this size drew attention.

Crescent Discovery Series cover: AI could cut second-line UTI antibiotics by two-thirds

A model picked narrower drugs without missing infections.

Source

  1. Kanjilal, S., Oberst, M., Boominathan, S., Zhou, H., Hooper, D. C., & Sontag, D. (2020). A decision algorithm to promote outpatient antimicrobial stewardship for uncomplicated urinary tract infection. Science Translational Medicine, 12(568). https://doi.org/10.1126/scitranslmed.aay5067
Crescent Discovery Series

Follow the series

New discoveries are published on our channels every day.

Keep going

Three more numbers